Persistent immune system activation plays an important role in the development of various forms of hypertension. Activation of the innate immune system, inflammation, and subsequent adaptive immune system response causing end-organ injury and dysfunction ultimately leads to hypertension and its associated sequelae including coronary artery disease, heart failure, stroke, and chronic kidney disease. In this review, we will provide updates on the innate and adaptive immune cells involved in hypertension, the current understanding of how the immune system gets activated, and examine the recently discovered mechanisms involved in several forms of experimental hypertension.
The continuing rise in the incidence of several forms of hypertension is concerning as therapies are becoming less effective or remain nonexistent as in the case of hypertensive disorders of pregnancy. The recent SPRINT clinical trial results suggest that clinicians should intensively treat blood pressure with several medications which will affect patient compliance, while at the same time the incidence of treatment-resistant hypertension is increasing similar to that of hypertensive disorders of pregnancy. 1 In order to develop more effective therapies an understanding of the underlying, progressive mechanisms involved in the development of hypertension is needed. In recent years, this has come in the form of how the immune system affects blood pressure regulation. Numerous immune cells in both the innate and adaptive systems have been found to play important roles in the development and maintenance of hypertension. In addition, across the various forms of hypertension there tends to be both common and type-specific mechanisms involved which will be discussed here. Nonetheless, a targeted approach to inhibit the effector arm or to scavenge the stimuli and antigens thus removing the signals for immune system activation may provide clinicians with a more effective and efficient therapeutic in the near future.
IMMUNE SYSTEM
In medicine, concepts of immunology have many applications in the diagnosis, treatment, preventions, and pathogenesis of diseases. Regardless, understanding of the organization, interactions, and mechanisms of this complex and multiorgan integrated system can be a challenge.
Mechanisms linking the immune response to some diseases, like hypertension, are still vague. The immune system works to restore system homeostasis by detecting, protecting, and eradicating harmful foreign antigens and neoantigens that enter or arise, respectively, in the body. The body's first line of defense is called the innate response. It is present at birth and does not change drastically throughout the course of an individual's life. Adaptive immunity, the body's second line of defense, is a delayed response. It retains memory of the antigen leading to a more rapid response in future encounters.
INNATE IMMUNITY
The innate immune response is activated by chemical properties of the antigen. Nonspecific defenses of the innate system include physical barriers like skin, chemicals in the blood, and innate immune cells. Macrophages, dendritic cells (DCs), mast cells, granulocytes, complement proteins, and inflammatory mediators are the key players of the innate immune response. 2 All of these leukocytes are produced in the bone marrow. Innate cells become activated when they sense pathogen-associated molecular patterns or damageassociated molecular patterns (DAMPs) including neoantigens from stressed or injured tissue via pathogen recognition receptors (PRRs). These effector cells initiate host defense and inflammation directly via phagocytosis, cytokine and chemokine production, and activation of complement system proteins or indirectly by activation of the adaptive immune response via antigen presentation. 2 Antigen presenting cells (APCs) include monocytes, macrophages, and DCs. Monocytes are large leukocytes that differentiate into macrophages and DCs. Monocytes turn into macrophages when they migrate out of the bloodstream and enter tissues. Macrophages and DCs, as well as granulocytes (leukocytes characterized by their unique segmented nuclei and granules), are able to ingest antigens making them phagocytic. A phagocyte's main function is to patrol the body via the bloodstream in search of invading antigens or neoantigens. The phagocyte will engulf the pathogen and create a phagosome inside. The antigen gets degraded into smaller fragments inside of the phagosome, and then these peptide fragments are attached to a MHC Class II complex and placed on the surface of the cell. The most effective and efficient APCs are DCs. DCs play an important role in the innate response in areas like the skin, intestines, and respiratory epithelium. Monocytes and their descendants contain Toll-like receptors (TLRs) and granules. TLRs are the most well-known and studied PRRs. TLRs are transmembrane proteins that recognize pathogen-associated molecular patterns and DAMPs in the extracellular or endosomal compartments. Different TLRs recognize molecular patterns from different antigens. Not only can they signal the presence of a specific antigen, they can trigger a downstream signaling pathway resulting in production of proinflammatory cytokines and activation of adaptive immunity.
Leukocytes that have granules capable of staining are characterized as granulocytes. Granulocytes include neutrophils, basophils, eosinophils, and mast cells. Their granules contain enzymes that digest antigens and release inflammatory mediators into the bloodstream. Basophils are responsible for short-term inflammatory responses by releasing histamine and heparin. Mast cells function similarly to basophils as both release their granules when they bind to anaphylatoxins and lectins. This stimulation results in the fusion of the intracellular granules with the surface membrane and the release of their contents to the exterior by the process of exocytosis. Basophils are present in very low numbers in the circulation. Eosinophils have some phagocytic activity but are primarily responsible for extracellular killing of large parasites which can't be phagocytosed. Antibodies that bind to the surface of the parasites activate mast cells and bring eosinophils to the parasite via Fc receptors where they release their granule contents, peroxides, and toxins that kill the parasite. Neutrophils are the largest subset of white blood cells. They are very abundant and act very quickly. Neutrophils are the first to migrate during an inflammatory event. They are attracted to the site of inflammation by chemotactic factors to defend against bacterial and fungal infections. They can phagocytose antigens, but they do not act as APCs. Instead, they cause necrosis leaving the site purulent. After the initial neutrophil response is typically when monocytes and macrophages arrive at the site of inflammation to clean up dead neutrophils, cellular debris, and remaining antigens.
The main function of natural killer (NK) cells is to kill virus-infected self-cells. NK cells do not carry antigen receptors. NK cells recognize normal self-cells but ignore them while killing infected or malignant self-cells. They do this by releasing granule contents like perforin and granzyme onto the infected cell's surface. Monocytes and macrophages stimulate NK cells to produce proinflammatory cytokines like interferon (IFN)-gamma which helps protect surrounding cells from virus infection, although IFN-alpha and IFN-beta are more important in this role. IFN-gamma can also enhance the development of specific T cell responses directed to virus-infected cells.
All APCs contain PRRs, however there are numerous other cell types that contain PRRs that can become activated to initiate or propagate an immune response. These include endothelial cells, vascular smooth muscle cells, trophoblasts, epithelial cells, and others. While they don't contain the machinery to process and present antigenic peptides in MHC molecules, their activation, signaling, and expression of adhesion molecules and chemokines are important in directing the immune response.
ADAPTIVE IMMUNITY
After an antigen-MHC Class II complex has been presented and recognized by B and T cells, the role of the adaptive or specific immune system is to create immune cells that specifically attack that antigen. 2 The adaptive response will also remember that antigen so that the body can elicit a quicker and more effective response to that antigen in the future. Adaptive or specific immunity is further divided into humoral immunity and cell-mediated immunity. B cells participate in the humoral response when the antigen is floating free in the extracellular space while T cells participate in the cell-mediated response, necessary when the antigen has infiltrated cells. 2 B and T cells mature in the bone marrow and thymus, respectively. A progenitor lymphoid cell can give rise to either naïve B cells or naive T cells. The naïve T cells have T cell receptors on their surface that can recognize an antigen. If a T cell recognizes a self-antigen, this naive T cell will be destroyed before it matures. When naive T cells proliferate and differentiate they will mature into CD4+ helper and CD8+ cytotoxic T cells. The naive CD8+ T cell will become an effective cytotoxic T cell once it is activated by the presentation of an infected APC carrying an antigen-MHC Class I complex. Type I MHCs are present on DCs along with all nucleated cells. Direct killing by cytotoxic T cells is mediated by secretion of perforin and granzyme which cause apoptosis of target cells. Naive CD4+ T cells will become an effective helper T (Th) cell when activated by a noninfected APC, predominantly DCs, that presents a foreign antigen in an MHC Class II complex. A T helper cell's main goal is to enhance the immune response by activating B cells, NK cells, and also macrophages or other phagocytes. Both CD4+ and CD8+ cells produce cytokines. There are a few subsets of proinflammatory Th cells: Th1, Th2, Th9, Th17, Th22, and T follicular helper. Different cytokines control which subtype the Th0 cell matures into. Interleukin (IL)-2 and IFNgamma will result in a commitment to a Th1 phenotype which secrete IL-2 and IFN-gamma prompting activation of macrophages and upregulation of iNOS. Th2 maturation is influenced by IL-4 and Th2 cells promote humoral immune responses and host defense against helminthic parasites. They also can heighten allergic responses and asthma. Th17 cells are controlled by transforming growth factor-beta, IL-6, and IL-1. Th17 cells promote protective immunity against extracellular bacteria and fungi, mainly at mucosal surfaces; however, they also play a role in the development of autoimmune and inflammatory diseases. Inducible regulatory T cells (iTregs) are generated from naive T cells in the periphery while natural Tregs (nTregs) are generated in the thymus. When transforming growth factor-beta is present and IL-6 concentrations are low, naive T cells will express the transcription factor Foxp3 and mature into Tregs. Tregs produce the anti-inflammatory cytokines IL-10 and transforming growth factor-beta which cause immunosuppressive and tolerogenic responses.
Naive B cells have PRRs that can recognize specific antigens. Like an APC, they will engulf the free antigen from the extracellular space, process it, and present it in MHC Class II to present to a Th cell. The naive B cell will then proliferate and differentiate into either memory B cells or plasma cells. Plasma cells secrete specific antibodies towards that antigen, but will not express membrane antibodies. Memory B cells form memory for that specific antigen so that if the body is re-introduced to the same antigen it can be resolved quickly. Antibodies can neutralize a pathogen by preventing bacterial adhesion, opsonize a pathogen by promoting phagocytosis, and activate complement by the classical pathway.
IMMUNE SYSTEM ACTIVATION IN HYPERTENSION
In order for immune system activation to occur, there must be an exogenous or endogenous stimulus or antigen to evoke immunity/autoimmunity. Exogenous activators that bombard people every day include bacteria, viruses, and other pathogens; diet-based factors such as salt, yeast, and fungi; radiation; and airborne pollutants. Endogenous activators include bacteria, viruses, cellular contents that are released upon cell death, and "self " molecules. The chronic exposure and resultant inflammation-induced tissue injury in blood pressure-regulating organs such as the brain, blood vessels, and kidneys are sufficient to cause hypertension in some people. This suggests that certain individuals are more susceptible to these factors and/or their immune system reacts differently to the same stimuli as another person. The exceeding of an immunological threshold may also elicit the clinical presentation of hypertension after the organ injury is severe enough, which will also differ between individuals based on their cellular repair capacities. Activation of PRRs appears to be at the forefront of innate immune system activation in hypertension (Figure 1 ).
The expression of highly conserved PRRs including TLRs, NOD-like receptors, and RIG-I-like receptors on immune and nonimmune cells such as endothelial cells, epithelial cells, and trophoblasts also help shape the innate immune response and its effects on the cardiovascular system. Exogenous pathogen-associated molecular patterns and endogenous DAMPs elicit an innate immune response by ligation of PRRs at various levels. The list of pathogen-associated molecular patterns and DAMPs is growing exponentially and the leading ones associated with hypertension currently include endotoxin, DNA, RNA, isoketals, HMGB-1, heat shock proteins, uric acid, and several viruses. Whether sodium itself is a DAMP or induces other DAMPs is currently being explored by several groups. The activation of PRRs on innate immune and other cells including vascular cells and the subsequent rapid immune response and inflammation likely causes the initial tissue injury which, when persistent and excessive, leads to activation of the adaptive immune system. The activation of APCs by (neo)antigens, the presentation of (neo)antigenic peptides by APCs to T and B lymphocytes with costimulation, and subsequent polarization and proliferation also contributes to hypertension (Figure 1 ). These adaptive immune cells propagate the inflammation and tissue injury by secreting proinflammatory cytokines such as IL-17, IL-6, and IFN, and cytotoxic molecules such as FAS ligand, perforin, and granzyme. While immunosuppression has been shown to reduce blood pressure in hypertensive humans and animals, it is not feasible to chronically suppress all myeloid, T, or B cells. Understanding the similarities and differences in immune system involvement in various forms of hypertension might produce a specific and targeted approach to lower blood pressure.
SPONTANEOUSLY HYPERTENSIVE RATS
The spontaneously hypertensive rats (SHR) has been used as a genetic model of essential hypertension for many years. This inbred rat strain was developed in Japan and has a prepubertal, prehypertension phase followed by the development of frank hypertension at around 6 weeks of age. Several groups have detailed the immunological contributions to the development of hypertension in these rats. SHRs have elevated TLR2, TLR4, and NFkB expression after hypertension develops and that inhibiting TLR4 activation decreases blood pressure, inflammation, and vascular reactivity. [3] [4] [5] SHRs also demonstrate an exacerbation in stroke effects due to the elevated levels of activated monocytes, macrophages, and granulocytes. 6 Further evidence of elevated innate immune system activity in SHRs is that SHR-derived bone marrow transferred into WKY controls was sufficient to increase blood pressure and that SHRs have increased expression of MCP-1 and CCR2, the major chemokine and its receptor for monocyte/macrophage infiltration. 7 Harwani et al. reported that prior to the spontaneous development of hypertension, SHRs have reduced nicotinic/cholinergic modulation of the innate immune system. 8 More recently this group demonstrated that nicotine-mediated renal infiltration of macrophages was able to evoke hypertension in prehypertensive SHRs. 9 In the early 1980's, it was reported that SHRs had reduced numbers of T cells and that restoring thymic function suppressed the development of hypertension. [10] [11] [12] It was later reported that SHRs had decreased levels of T nonhelper cells throughout their lifespan while at 4 months of age their total T cell levels were decreased compared to controls. 13 Considering the relatively recent characterization of anti-inflammatory Tregs it is possible that a reduction in this T cell subset may contribute. Female SHRs, who develop hypertension but less than their male counterparts, have increased renal anti-inflammatory T cell infiltration then males who experience renal proinflammatory T cell infiltration as early as 3 weeks of age. 14, 15 It was reported that one of the underlying genetic differences between the SHR-A3 strain that develops hypertension and kidney injury and the SHR-B2 strain that develops hypertension but not kidney injury involves the regulation of Tregs. [16] [17] [18] Despite a reduction in T cells in general, there is B cell involvement as autoantibodies toward the beta-1 adrenoceptor and other arterial antigens, as well as IgA levels, are elevated in SHRs. 19, 20 Immune system dysregulation plays a major role in the development of hypertension in SHRs as evidenced by the finding that mycophenolate mofetil reduces blood pressure in SHRs. 21 
SALT-INDUCED HYPERTENSION
In the general population, blood pressure is only modestly responsive to alterations in sodium intake; however, some individuals manifest significant changes in blood pressure in response to salt repletion or depletion. These individuals are termed "salt sensitive". Individuals with no blood pressure response to salt are "salt resistant". Factors that can bring upon salt sensitivity include genetics, race/ethnicity, age, body mass, diet, quality of lifestyle, and associated disease states, like hypertension, diabetes, and renal dysfunction. People who live in nonindustrial, uncultured communities who also ingest low levels of salt have on average low blood pressures that increase slightly with age. Blood pressure increases when such people adopt modern lifestyles. Many researchers have attempted to demonstrate the conversion from a salt-resistant state to a salt-sensitive state. High salt intake is associated with higher blood pressure and increased risks of stroke and cardiovascular disease. Currently, Americans consume about 1.5 times more sodium per day than what is recommended by the Centers for Disease Control. More than 75% of the sodium that Americans consume comes from processed food and restaurant meals.
Several experimental models of salt-sensitive hypertension exist and include deoxycorticosterone acetate/salt (DOCA/salt)-induced hypertension, the Dahl salt-sensitive rat, and Nω-nitro-l-arginine methyl ester hydrochloride/ high salt-induced hypertension. Studies establish a role for the immune system, T lymphocyte infiltration, and immune cytokines in hypertension. 22 Salt-sensitive hypertension resulting from pressor doses of angiotensin II (Ang II) is associated with renal infiltration and activation of immune cells. Immunosuppressive therapy can prevent the consequences of salt-sensitive hypertension as well as the elevation of blood pressure. Mycophenolate mofetil, a drug known to inhibit infiltration and proliferation of immune cells, prevents the development of salt-sensitive hypertension in rats. 23 A mechanistic explanation for the importance of T lymphocytes in the pathogenesis of hypertension in a high salt diet model has been explained using Dahl salt-sensitive rats. A high salt diet, with or without a high-protein diet on top of it, increases renal lymphocyte infiltration and through production of reactive oxygen species renal disease and hypertension are elicited. 24, 25 In DOCA/salt-treated Sprague-Dawley rats, Machnik et al. demonstrated that macrophages can acquire a proinflammatory (M1) role and an anti-inflammatory (M2) role in the skin by regulating salt and water retention that leads to higher blood pressure. 26, 27 Depletion of macrophages and DCs (cells of the mononuclear phagocyte system) by use of clodronate liposomes prevents the lymphatic proliferation and leads to hypertension in response to salt loading. 26 Additionally, this group found that salt loading increased macrophage accumulation in the skin and that these are stimulated to produce the vascular endothelial growth factor C, essential for lymphatic proliferation. 26, 27 Without the lymphatic expansion in the skin, interstitial hypertonic volume increases leading to salt-induced hypertension.
Experimental models of hypertension have provided convincing evidence of a genetic susceptibility to salt sensitivity. 28 Osteopetrotic mice have a mutation in the monocyte/ macrophage colony stimulating factor gene, a gene responsible for the differentiation, proliferation, and survival of macrophages, thus rendering them monocyte and macrophage deficient. DOCA/salt failed to elevate blood pressure, induce vascular remodeling, or produce endothelial dysfunction in Op/Op mice, whereas in heterozygous Op/+ mice the effects were intermediate demonstrating a role of innate immunity in vascular remodeling and blood pressure regulation. 29 Altering recombinase-activating gene 1 (Rag1) in mice and Dahl salt-sensitive rats produced animals that lacked T and B cells in the circulation and spleen. 30, 31 Not only was the hypertension caused by DOCA/salt in mice and a high salt diet in Dahl salt-sensitive rats significantly reduced, but excreted urinary albumin was also lowered. Adoptive transfer of T lymphocytes only restored the hypertensive response, indicating that T lymphocytes play an important role in the pathogenesis of salt-induced hypertension.
Replacement of chromosome 2 in the Dahl salt-sensitive rat with that of a Brown Norway rat (control normotensive strain) produced a new consomic strain of rat, SSBN2. Chromosome 2 has quantitative trait loci for hypertension and contains genes associated with hypertension, vascular reactivity, and immune responses. Systolic blood pressure was significantly higher in Dahl salt-sensitive rats (175 ± 3 mm Hg) than in Brown Norway rats (113 ± 5 mm Hg) and SSBN2 rats (150 ± 3 mm Hg, P < 0.01). 32 SSBN2 rats were found to have reduced aortic vascular inflammation and infiltration of Th lymphocytes that are normally found in Dahl hypertensive rats. SSB2 rats also had more Tregs, transforming growth factor-beta, and IL-10. The genetic substitution in the SSBN2 rats led to increased IL-10 production by these aortic Tregs compared to Tregs of Dahl salt-sensitive rats. These results suggested that Tregs participate in attenuating salt-sensitive hypertension. Similarly, myeloid-derived suppressor cells (MDSCs), which directly and indirectly suppress both innate and adaptive immunity, were reported to also attenuate high salt-induced hypertension and renal damage in mice. 33 In 2 independent studies, it was reported that sodium chloride can increase Th17 cells by activating serum and glucocorticoid-regulated kinase 1 (SGK1) which regulates IL-23 receptor expression. 34, 35 IL-23 receptor is responsible for stabilizing and reinforcing Th17 cell's proinflammatory phenotype. The Th17 cells produced under high salt conditions are highly pathogenic and stable. The high salt conditions activated SGK1 during cytokine-induced Th17 polarization and silencing SGK1 prevented the high salt-induced Th17 development. Th17 cells are capable of secreting IL-17, known to cause hypertension, and there is an intriguing relationship between IL-17 and salt intake. 36 Kamat et al. demonstrated that there was an improved susceptibility to excrete salt and reduction in blood pressure in mice lacking IL-17A and IFN-gamma, suggesting that these cytokines have an influence on renal sodium transporters and hypertension. 22 Lastly, the influence of DC-T cell cross-talk in hypertension was examined by the use of abatacept, a drug used to treat autoimmune diseases by interfering with the immune activity of T lymphocytes by blocking CD80 and CD86 on DCs. 37 Blocking CD80 prevented the activation and maturation of T lymphocytes and the treatment attenuated DOCA/ salt-induced hypertension. More recently, the influence of DCs in salt-sensitive hypertension was demonstrated in a murine Nω-nitro-l-arginine methyl ester hydrochloride/ high salt diet model. 38 The salt-sensitive mice exhibited increased macrophage and DC surface expression of CD70 and accumulation of effector memory T cells in the kidney and bone marrow. Mice lacking CD70 did not develop hypertension which was associated with a lack of renal effector memory T cells.
ANG II-INDUCED HYPERTENSION
In contrast to a low renin, salt-sensitive model of hypertension, Ang II-induced hypertension in animals involves high levels of renin while immunity and inflammation also play contributing roles. Similar to sodium, it is currently being explored whether Ang II acts as a DAMP or simply induces other DAMPs. Nonetheless, Ang II signaling is able to activate TLR4 and various innate immune cells that contribute to the vascular dysfunction, vascular remodeling, and hypertension and inhibiting TLR4 prevented these effects in mice. 39 Monocyte/macrophage activation and tissue infiltration play a role as depletion of these cells reduced vascular dysfunction and hypertension which was associated with decreased vascular wall infiltration in Ang II-treated mice. 40 This may be due to a decrease in IL-1, which upon activating its receptor, IL-1R1, was reported to contribute to Ang II hypertension by causing sodium reabsorption via NKCC2. 41 Op/Op mice that have functionally deficient macrophages also have reduced blood pressure and vascular remodeling compared to wild-type Ang II hypertensive mice. 42 In addition to monocytes, NK cells were also determined to contribute to Ang II-induced vascular dysfunction. 43 DCs also play a major role in Ang II hypertension and it was demonstrated that DCs recognize and present isoketals to T cells that then become activated and proinflammatory. 44 Protein modifications due to hypertensive stimuli may serve as neoantigens that innate immune cells will process and present to adaptive immune cells. It is likely that all innate immune cells that recognize antigens/neoantigens play an initiating role in the development of hypertension.
The adaptive immune response has been better characterized in this model of hypertension and several groups have determined how both T and B cells contribute to Ang II hypertension. The loss of the lymphocyte adaptor protein LNK was determined to exacerbate the inflammation, end-organ dysfunction, and hypertension in response to low-dose Ang II. 45 Sympathetic nerve activity can directly influence the activation of T cells as increased central sympathetic nerve activation by Ang II caused systemic immune responses and AV3V lesions can prevent Ang II hypertension and T cell activation. 46, 47 A recent study by Carnevale et al. determined that activation of adrenergic nerves to the spleen leads to placental growth factor production which is necessary for splenic T cell activation and egress following Ang II. In a series of studies, they demonstrated that splenectomy prevented Ang II hypertension and that mice transplanted with spleens from placental growth factor deficient mice had blunted responses to Ang II. 48 So which T cells are important and where do they go after leaving the spleen?
Similar to SHRs and salt-sensitive models of hypertension, proinflammatory immune cell infiltration into blood pressure-regulating organs including the brain, blood vessels, and the kidney play a major role in Ang II hypertension. It was determined that T cells were needed for the maintenance of Ang II hypertension, that co-stimulation was necessary for Ang II-induced T cell activation, and that CD8+ T cells appear to be the primary activated T cell in addition to double negative T cells (CD3+CD4−CD8−). 31, [3] [4] [5] [6] [7] 49, 50 Crowley et al. demonstrated in SCID mice that the lack of an adaptive immune system was protective against Ang II hypertension. 51 In Ang II hypertensive rats, T cell subset imbalance was also found with an increase in Th1 cells while Th2 cells were decreased. 52 Similarly, mice with human immune cells developed Ang II hypertension which was associated with increased organ infiltration of CD4 and memory T cells, and this was due directly to the elevation in pressure. 53 Th17 cells also play a role in Ang II hypertension and their primary secreted cytokine, IL-17, is known to directly induce endothelial dysfunction and hypertension. 36, 54 Other proinflammatory T cell-derived cytokines that negatively affect the heart, kidney, and blood vessels in Ang II hypertension include IL-6, IFN-gamma, IL-1-beta, and TNF-alpha. 22, [55] [56] [57] While proinflammatory T cells (i.e., Th1, Th17, etc.) play a role in the maintenance of Ang II hypertension, Tregs are able to reduce the hypertension and end-organ damage caused by high levels of Ang II. Barhoumi et al. demonstrated that Ang II treatment reduces Treg levels and that adoptive transfer of Tregs prior to Ang II treatment was able to prevent the hypertension and vascular injury and dysfunction. 58 Similarly, Tregs and their release of IL-10 were demonstrated to improve coronary artery function in Ang II hypertensive mice and decrease blood pressure. 59, 60 Another study reported that although Treg adoptive transfer one day after beginning Ang II treatment was not able to prevent the increase in mean arterial blood pressure in mice, Treg therapy was able to reduce immune cell infiltration into the heart and attenuated Ang II-induced cardiac hypertrophy and fibrosis. 61 In contrast to a decrease in Tregs, hypertension induced by Ang II is associated with an increase in immunosuppressive MDSCs, similar to that observed in salt-sensitive hypertensive mice. Augmenting MDSC levels was reported to reduce inflammation and blood pressure in this model of hypertension as well. 33 Lastly, recent work has highlighted an important role for B cells in Ang II hypertension. It was reported that B cells and their secreted IgGs play an important role in the development of Ang II hypertension. 62 Mice made deficient in B cells either genetically or pharmacologically still developed Ang II hypertension; however, systolic blood pressures and vascular remodeling were reduced compared to Ang II hypertensive mice. This, coupled with the finding that adoptive transfer of B cells into Ang II-treated mice deficient in T cells had no effect on blood pressure, 31 suggests that the antigen presenting function of B cells is important in Ang II hypertension. These findings together demonstrate the importance of keeping immunity and inflammation in check and how it affects organ function and blood pressure.
HYPERTENSIVE DISORDERS OF PREGNANCY
Hypertensive disorders of pregnancy negatively affect both the mother and fetus and the incidence is rising. Preeclampsia (PE) is the most common form and is diagnosed by the de novo development of hypertension plus new-onset proteinuria, thrombocytopenia, impaired liver function, renal insufficiency, pulmonary edema, or cerebral or visual disturbances. 63 Eclampsia is the development of seizures in women with PE. Other hypertensive disorders of pregnancy include chronic hypertension, which is high blood pressure prior to conception or before 20 weeks of gestation, chronic hypertension with superimposed PE, and gestational hypertension. All forms are associated with excessive inflammation and endothelial dysfunction.
The immunological aspect to pregnancy involves the mother accepting a partly paternally derived fetus to develop. Thus, fetal-maternal tolerance is crucial to successful pregnancy and the loss of tolerance has been suggested to underlie numerous gestational disorders including preterm birth, PE, and spontaneous abortion. The innate immune system plays an important role in allowing the formation of the placenta, maternal vascular remodeling, and parturition. Excessive innate immunity and subsequent cytotoxicity is evident in hypertensive disorders of pregnancy and result from a variety of insults/stimuli. [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] PRR activation and/or upregulation is evident in placental and other gestational tissues from women with PE. [75] [76] [77] [78] [79] [80] [81] [82] [83] Further support for an important role in hypertensive disorders of pregnancy is that direct PRR activation can induce a pregnancy-dependent PE-like phenotype in rodents. 75, [84] [85] [86] [87] [88] [89] The dampening of the inflammation and cytotoxicity elicited by PRR-activated innate immune cells in PE has been reported to be a successful therapeutic strategy in animals. [90] [91] [92] [93] [94] DC, monocyte/macrophage, and neutrophil activation contributes to the excessive inflammation and cellular necrosis characteristic of hypertensive disorders of pregnancy. 66, 92, [95] [96] [97] [98] Circulating NK cell levels tend to be increased in women with PE compared to normotensive women; however, uterine NK cells are generally dysfunctional in women with PE. [99] [100] [101] Less is understood about how CD3 + /gammadelta + T cells contribute to hypertensive disorders of pregnancy in women; however, it was reported that these T cells from women with PE produce more IFN-gamma and perforin than the same cells from normal pregnant women. 102, 103 We reported that CD3 + /gamma-delta + T cells were increased in mouse models of PE and were reduced by various therapies that attenuated the TLR-induced inflammation, hypertension, and proteinuria in mice. 91, 92 T helper and T effector cells play a role in the development of hypertension during pregnancy as their levels and the proinflammatory cytokines they produce are typically increased in women with PE. 101, [104] [105] [106] [107] [108] Animal models of PE support these findings as elevated levels of Th1 and Th17 cells and their prototypical cytokines IFN-gamma and IL-17, respectively, have been reported in mice and rats. 84, [109] [110] [111] Additionally, activated T cells transferred into normal pregnant mice and rats can increase blood pressure and produce a PE-like phenotype. 110, 112, 113 Tregs, regulatory NK cells, and MDSCs on the other hand exhibit immunosuppressive functions which are beneficial during pregnancy. 114, 115 These regulatory cells play an important role in establishing fetomaternal tolerance and dampening inflammation and immunity when needed during pregnancy. 116 A decrease in the number of these cells and/ or loss of immunosuppressive function is associated with a number of pregnancy disorders including PE while augmenting them may be beneficial in women with PE. [117] [118] [119] [120] [121] Similarly, TLR-induced PE in mice was associated with a decreased percentage of MDSCs compared to normal pregnant mice and co-treatment with IL-4 and IL-10 normalized MDSC levels to normal pregnant levels while normalizing blood pressure and urinary protein excretion. 92 Lastly, B cells also contribute to hypertensive disorders of pregnancy as the presence of B cells in the placenta is associated with PE. 122 Women with PE and various animal models exhibit elevated levels of autoantibodies against the Ang II AT1 receptor as well as the endothelin receptor. [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] Perhaps a temporary reduction in B cells during pregnancy may attenuate the severity of PE. Identification of the stimuli that cause the activation of B cells either directly or indirectly and the subsequent production of autoantibodies during pregnancy needs to be addressed.
CONCLUSIONS AND FUTURE DIRECTIONS
There are numerous factors that were not discussed in this review including how human leukocyte antigens, MHC, prooxidants, cytokines and chemokines, and the complement system affect immunity and contribute to different forms of hypertension including hypertension evident in autoimmune diseases. The complexity of the immune and cardiovascular system interaction makes it difficult to pinpoint exact etiologies, and the examination of how the immune system contributes to human hypertension is also challenging. However, this also opens up a plethora of targeted therapeutic strategies for treating hypertension. Inhibiting TLR activation, augmenting regulatory cells, depleting proinflammatory cells, altering immune cell trafficking, supplementing anti-inflammatory cytokines, and sequestering proinflammatory cytokines are just a few of the many ways to dampen immunity and hopefully reduce the incidence and severity of hypertension in people.
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